Recent strides in lipid-based nanoparticle-mediated co-delivery systems for bone cancer management: A comprehensive review
Authors:
- Utkarsh U. BhamareUBUtkarsh U. Bhamare
- Vaibhav K. PatilVPVaibhav K. Patil
- Mahesh B. PalkarMPMahesh B. Palkar
- 21 November 2025
- journal article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 115
Abstract
No abstract availableThis publication has 138 references indexed in Scilit:
- A landscape of recent advances in lipid nanoparticles and their translational potential for the treatment of solid tumorsBioengineering & Translational Medicine, 2023
- Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapyMedcomm, 2023
- Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory DiseasesAdvanced Healthcare Materials, 2022
- Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcomaIUBMB Life, 2022
- PEGylated Nanoparticles as a Versatile Drug Delivery System2021
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- Viscosity–temperature relationship of lipid‐based excipients amenable for spray congealing: Derivation of a rheological parameter with good correlation to particle sizeEuropean Journal of Lipid Science and Technology, 2015
- The Role of Bone Microenvironment, Vitamin D and Calcium2012
- Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer CellsSmall, 2009
- Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical marginsCancer, 1993